The Scientist

» industry

Most Recent

image: Industry Funds Limit Freedom: Report

Industry Funds Limit Freedom: Report

By | November 27, 2013

A report by a Canadian organization finds that industry-academia relationships compromise university investigators' liberty.  

0 Comments

image: Opinion: AIA Does Not Discriminate

Opinion: AIA Does Not Discriminate

By | August 21, 2013

The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.

5 Comments

image: Opinion: Racing Toward Invention

Opinion: Racing Toward Invention

By | July 23, 2013

A newly instated patent law discriminates against academics and small biotechs.

6 Comments

image: Innovation Nation

Innovation Nation

By | July 1, 2013

Already a world leader in high-tech entrepreneurship, Israel is now flexing its biotech muscles.

1 Comment

image: BPTW: By The Numbers

BPTW: By The Numbers

By | June 1, 2013

Take a closer look at some of the statistics generated by The Scientist's Best Place to Work Industry 2013 survey.

0 Comments

image: Best Places to Work Industry 2013

Best Places to Work Industry 2013

By | June 1, 2013

Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.

1 Comment

image: Philip Low: Sleep Analyzer

Philip Low: Sleep Analyzer

By | January 1, 2013

Founder, Chairman, and CEO, NeuroVigil, Age: 33

2 Comments

image: Gold Dust Missing from Pfizer Lab

Gold Dust Missing from Pfizer Lab

By | December 10, 2012

$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.

1 Comment

image: Feds Scrutinize Genomics Merger

Feds Scrutinize Genomics Merger

By | December 6, 2012

A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.

2 Comments

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Mirus
Mirus
Advertisement
NeuroScientistNews
NeuroScientistNews